title: Acute leukemia of plasmablastic type as terminal phase of multiple myeloma.
authors.affiliation: Divisione di Oncologia Via del Pozzo 71, 41100 Modena, Italy piccinini@unimo.it
authors.forename: Lino
authors.initials: L
authors.lastname: Piccinini
authors.forename: Tullio
authors.initials: T
authors.lastname: Artusi
authors.forename: Goretta
authors.initials: G
authors.lastname: Bonacorsi
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Arigliano
mesh_terms: D000208:Acute Disease; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002999:Clone Cells / Q000473:pathology; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000008:administration & dosage; D018450:Disease Progression; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D015326:Gene Rearrangement, B-Lymphocyte, Heavy Chain; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000209:etiology*; D007953:Leukemia, Radiation-Induced / Q000209:etiology*; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D016609:Neoplasms, Second Primary / Q000209:etiology*; D014411:Neoplastic Stem Cells / Q000473:pathology; D016133:Polymerase Chain Reaction; D011241:Prednisone / Q000008:administration & dosage; D011878:Radiotherapy / Q000009:adverse effects*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D008558:Melphalan; D011241:Prednisone